Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
09/2000
09/28/2000CA2366691A1 48 human secreted proteins
09/28/2000CA2366650A1 Oral low dose butyrate compositions
09/28/2000CA2366552A1 Method for detecting superantigen activity in a biological sample
09/28/2000CA2366267A1 49 human secreted proteins
09/28/2000CA2366214A1 Dsp-2 dual-specificity map kinase phosphatase
09/28/2000CA2366132A1 48 human secreted proteins
09/28/2000CA2365405A1 Human tumor necrosis factor receptor-like 2
09/28/2000CA2365255A1 Human tumor necrosis factor receptor tr9
09/28/2000CA2365247A1 49 human secreted proteins
09/28/2000CA2365243A1 Human transmembrane proteins
09/28/2000CA2365238A1 48 human secreted proteins
09/28/2000CA2365223A1 46 human secreted proteins
09/28/2000CA2365104A1 Anti-p53 antibodies
09/28/2000CA2361221A1 Novel protein which induces chondrocyte differentiation
09/28/2000CA2361055A1 Viral agents
09/27/2000EP1038967A2 Virus with modified binding moiety specific for the target cells
09/27/2000EP1038962A1 Peptidoglycan biosynthetic gene murF from Streptococcus pneumoniae
09/27/2000EP1038959A1 Factor VIII without B-domain, comprising one or more insertions of a truncated intron I of factor IX
09/27/2000EP1038958A1 HUMAN Nap1 PROTEIN
09/27/2000EP1038952A2 Processes for preparation of Marek's Disease Virus using continuous avian cell lines
09/27/2000EP1038530A2 Immunomodulator comprising DNA
09/27/2000EP1038027A1 Decreasing cell proliferation by decreasing levels of pp5
09/27/2000EP1038025A1 Genetic alterations associated with cancer
09/27/2000EP1038019A1 NOVEL ribB
09/27/2000EP1038017A2 The use of consensus sequences for targeted homologous gene isolation and recombination in gene families
09/27/2000EP1038016A2 Needle-free injection of formulated nucleic acid molecules
09/27/2000EP1038011A2 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system
09/27/2000EP1037994A1 Peptide antagonists of vascular endothelial growth factor
09/27/2000EP1037993A2 A new gene called oligophrenin 1, its expression product, and the diagnostic and therapeutic applications thereof
09/27/2000EP1037989A2 Nucleotide and protein sequence of mammastatin and methods of use
09/27/2000EP1037987A2 14-3-3$g(s) ARRESTS THE CELL CYCLE
09/27/2000EP1037985A1 Restin and methods of use thereof
09/27/2000EP1037984A1 Cadherin-like polypeptides, methods and compositions related thereto
09/27/2000EP1037983A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof
09/27/2000EP1037981A1 Soluble inhibitors of vascular endothelial growth factor and use thereof
09/27/2000EP1037974A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
09/27/2000EP1037925A2 Antagonists of neuropilin receptor functional and use thereof
09/27/2000EP1037922A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof
09/27/2000EP1037918A1 Method and composition to enhance the efficacy of a vaccine using chemokines
09/27/2000EP1037916A2 Erythrovirus and its applications
09/27/2000EP1037915A1 Matrix-remodeling genes
09/27/2000EP1037910A2 Maintenance of smooth muscle integrity by morphogenic proteins
09/27/2000EP1037903A1 Peptide-based gemini compounds
09/27/2000EP1037900A1 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies
09/27/2000EP1037899A1 Secreted proteins and polynucleotides encoding them
09/27/2000EP1037898A1 Secreted proteins
09/27/2000EP1037670A2 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases
09/27/2000EP1037669A1 Therapeutic use of lentiviral vectors
09/27/2000EP1037668A1 Transfection particles
09/27/2000EP1037663A2 Methods to treat undesirable immune responses
09/27/2000EP1037662A1 Method to enhance an immune response of nucleic acid vaccination
09/27/2000EP1037660A1 ribB
09/27/2000EP1037654A1 ribA
09/27/2000EP1037611A1 Biodegradable mixed polymeric micelles for gene delivery
09/27/2000EP1037530A1 ribG
09/27/2000CN1268186A i (in vivo) use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes
09/27/2000CN1268059A Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery
09/27/2000CN1267519A Immune regulator, immune regulator food and immune regulator fodder
09/26/2000US6124448 Nucleic acid primers and probes for the mammalian OB gene
09/26/2000US6124445 Phosphotriester oligonucleotides, amidities and method of preparation
09/26/2000US6124439 OB polypeptide antibodies and method of making
09/26/2000US6124433 Polypeptide for use in the detection and monitoring of atherosclerosis, ischemia, hypertension, restenosis, and arterial inflammation
09/26/2000US6124310 Enediyne compounds
09/26/2000US6124270 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
09/26/2000US6124131 Protein associated with incresed oxygen demand; for treatment and prevention of tissues damage caused by lack of oxygen
09/26/2000US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides
09/26/2000US6124104 Chromosome 13-linked breast cancer susceptibility gene
09/26/2000CA2283470A1 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3)
09/21/2000WO2000055633A2 Methods of screening for colorectal cancer modulators
09/21/2000WO2000055378A1 Lentiviral vector system for high quantity screening
09/21/2000WO2000055371A1 27 human secreted proteins
09/21/2000WO2000055352A2 50 human secreted proteins
09/21/2000WO2000055351A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000WO2000055350A1 Human cancer associated gene sequences and polypeptides
09/21/2000WO2000055345A2 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes
09/21/2000WO2000055343A2 Retrovirus producting cells utilizing a high multiplicity of transduction
09/21/2000WO2000055341A1 Anti-viral vectors
09/21/2000WO2000055335A1 Pseudotyped lentiviral vectors and uses thereof
09/21/2000WO2000055332A2 Human regulators of intracellular phosphorylation
09/21/2000WO2000055326A1 Chlamydia antigens and corresponding dna fragments and uses thereof
09/21/2000WO2000055323A1 Differential expression of organellar gene products
09/21/2000WO2000055320A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000WO2000055318A2 Abc1 polypeptide and methods and reagents for modulating cholesterol levels
09/21/2000WO2000055201A1 49 human secreted proteins
09/21/2000WO2000055200A1 50 human secreted proteins
09/21/2000WO2000055199A1 47 human secreted proteins
09/21/2000WO2000055194A2 Tuberculosis antigens and methods of use therefor
09/21/2000WO2000055192A2 Hemocyanin and nucleic acid sequence coding for the same
09/21/2000WO2000055180A2 Human lung cancer associated gene sequences and polypeptides
09/21/2000WO2000055177A2 49 human secreted proteins
09/21/2000WO2000055175A1 50 human secreted proteins
09/21/2000WO2000055174A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000WO2000055173A1 Human breast and ovarian cancer associated gene sequences and polypeptides
09/21/2000WO2000055171A1 50 human secreted proteins
09/21/2000WO2000055169A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS
09/21/2000WO2000054813A2 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
09/21/2000WO2000054805A1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS
09/21/2000WO2000054796A1 Novel antiangiogenic peptides
09/21/2000WO2000054787A1 Enhanced gamma-carboxylation of recombinant vitamin k-dependent clotting factors
09/21/2000WO2000054786A1 Methods and compositions for tolerizing hosts for long term survival of tissue transplants
1 ... 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 ... 870